Mouse strains B10, B10.RIII, RIIIS/J and the F1 and backcross progeny
arising from them were tested for susceptibility to porcine type 11 co
llagen-induced arthritis (PII-CIA). The clinically severe arthritis of
rapid onset that is characteristic of PII-immunized B 10.RIII mice de
veloped predominantly in hybrid offspring that had inherited at least
one copy of wild type T cell receptor (TCR) genes (Vbeta(b) genotype)
from the B10 or BIO.RIII parent. The results indicate that, in the dev
elopment of PII-CIA, mice expressing the H-2(r/r) haplotype preferenti
ally utilize TCR Vbeta genes that are normally encoded within the TCR
Vbeta genomic deletion region of RIIIS mice (Vbeta(c)). After aggressi
ve immunization with PII, the use of alternative TCR Vbeta genes, enco
ded outside of the RIIIS deletion region, produced a high IgG antibody
response that was cross-reactive with mouse type II collagen (MII) an
d equivalent to that of B 10.RIII mice, but only a very mild, late ons
et arthritis of 56% (27/48) incidence in RIIIS male mice and 28% (10/3
5) incidence in RIIIS female mice. In comparison, B10.RIII mice routin
ely developed early onset of PII-CIA of significantly higher incidence
(100%; p<0.005) and four-fold greater severity, even after milder imm
unization protocols. The data are compatible with the proposal that th
e clinically weak CIA response of RIIIs mice may be primarily antibody
driven while the severe CIA of B10.RIII mice reflects the added infla
mmatory effects of collagen-reactive effector-T cells in the joint. Th
e apparent concordance of TCR Vbeta utilization in the murine T cell r
esponse to MAM (a superantigen produced by M. arthritis), to Mls-1a (a
retroviral superantigen), and to homologous type II collagen is discu
ssed.